SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009042
Filing Date
2024-03-06
Accepted
2024-03-06 16:35:16
Documents
15
Period of Report
2024-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40089
2 ex3-1.htm EX-3.1 238273
  Complete submission text file 0001493152-24-009042.txt   493356

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pali-20240306.xsd EX-101.SCH 3024
4 XBRL LABEL FILE pali-20240306_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pali-20240306_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3736
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 24726452
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)